找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cancer Chemotherapy 1; F. M. Muggia Book 1983 Martinus Nijhoff Publishers, The Hague 1983 Staging.antibiotics.cancer treatment.gastric can

[復制鏈接]
查看: 18348|回復: 48
樓主
發(fā)表于 2025-3-21 18:50:15 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Cancer Chemotherapy 1
編輯F. M. Muggia
視頻videohttp://file.papertrans.cn/222/221073/221073.mp4
叢書名稱Cancer Treatment and Research
圖書封面Titlebook: Cancer Chemotherapy 1;  F. M. Muggia Book 1983 Martinus Nijhoff Publishers, The Hague 1983 Staging.antibiotics.cancer treatment.gastric can
描述Where do you begin to look for a recent, authoritative article on the diagnosis or management ofa particular malignancy? The few general onco- logy textbooks are generally out of date. Single papers in specialized journals are informative but seldom comprehensive; these are more often prelimi- nary reports on a very limited number of patients. Certain general journals frequently publish good indepth reviews of cancer topics, and published symposium lectures are often the best overviews available. Unfortunately, these reviews and supplements appear sporadically, and the reader can nev- er be sure when a topic of special interest will be covered. Cancer Treatment and Research is a series of authoritative volumes which aim to meet this need. It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription. We have approached the problem in the following fashion. First, by div- iding the oncology literature into specific subdivisions such as lung cancer, genitourinary cancer, pediatric oncology, etc. Second, by a
出版日期Book 1983
關(guān)鍵詞Staging; antibiotics; cancer treatment; gastric cancer; leukemia; tumor
版次1
doihttps://doi.org/10.1007/978-1-4613-3903-8
isbn_softcover978-1-4613-3905-2
isbn_ebook978-1-4613-3903-8Series ISSN 0927-3042 Series E-ISSN 2509-8497
issn_series 0927-3042
copyrightMartinus Nijhoff Publishers, The Hague 1983
The information of publication is updating

書目名稱Cancer Chemotherapy 1影響因子(影響力)




書目名稱Cancer Chemotherapy 1影響因子(影響力)學科排名




書目名稱Cancer Chemotherapy 1網(wǎng)絡公開度




書目名稱Cancer Chemotherapy 1網(wǎng)絡公開度學科排名




書目名稱Cancer Chemotherapy 1被引頻次




書目名稱Cancer Chemotherapy 1被引頻次學科排名




書目名稱Cancer Chemotherapy 1年度引用




書目名稱Cancer Chemotherapy 1年度引用學科排名




書目名稱Cancer Chemotherapy 1讀者反饋




書目名稱Cancer Chemotherapy 1讀者反饋學科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 21:49:52 | 只看該作者
N. Freckmann,H.-D. Herrmann,D. Winklers with a wider scope [1–3] and reviews of NCI contract studies [4] have collected relevant information either on single drug scheduling [4] or on combination therapy [1–3]. A more general review of the validity of animal models has been presented by Carter [5].
板凳
發(fā)表于 2025-3-22 04:05:36 | 只看該作者
地板
發(fā)表于 2025-3-22 06:56:54 | 只看該作者
5#
發(fā)表于 2025-3-22 12:08:37 | 只看該作者
6#
發(fā)表于 2025-3-22 13:45:17 | 只看該作者
J. Moret,A. Boulin,L. CastaingsA primary purpose for the employment of animal models in cancer chemotherapy is to identify compounds, either synthetic or derived from natural products, which will be active in the clinic. The features of a comprehensive preclinical chemotherapy program designed to introduce compounds into the clinic may be summarized as follows [1–8]:
7#
發(fā)表于 2025-3-22 20:40:06 | 只看該作者
8#
發(fā)表于 2025-3-23 00:45:25 | 只看該作者
9#
發(fā)表于 2025-3-23 03:40:12 | 只看該作者
The Human Tumor Cloning Assay: An , Assay for Antitumor Activity in Solid Tumors,re used in the treatment of infectious disease. Such a test would allow the rapid screening of potential anticancer agents for activity and might allow the selection of appropriate chemotherapy for an individual patient’s tumor.
10#
發(fā)表于 2025-3-23 05:52:01 | 只看該作者
Therapy of Acute Myelogenous Leukemia, Infiltration of the bone marrow by these leukemia cells results in the impairment of normal hematopoiesis with resultant anemia, granulocytopenia and thrombocytopenia. If untreated, the disease is rapidly fatal, with a median survival of less than two months. Death frequently results from infection, hemorrhage or both [1].
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-2-1 18:33
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
东明县| 尉犁县| 广河县| 海口市| 汉中市| 饶阳县| 客服| 旅游| 大埔县| 泰宁县| 玛曲县| 左权县| 康马县| 铜山县| 石泉县| 江阴市| 会理县| 阳东县| 邢台市| 乌恰县| 合肥市| 凯里市| 托里县| 利辛县| 海原县| 宜黄县| 宝兴县| 肃南| 临江市| 灵山县| 云龙县| 呼和浩特市| 德安县| 砚山县| 正宁县| 建德市| 广元市| 芒康县| 肇庆市| 陆河县| 通城县|